COLGATE PALMOLIVE CO
NYSE: CL·New York, New York·CIK 0000021665
- Price
- $100.99
- Base IV
- $82.50
Valuation snapshot
At $100.99, the price sits between our base case ($82.50) and bull case ($110.80).
Values per share, from an .
- No growth
- …
- Loading earnings power
- Base case
- $82.50
- 82% of the price · range $46.61–$110.80
- Price vs base case
- 22% above
- $100.99 against $82.50
- Base case · our researched forecast, 2026-11-11See the research ↗
- Price vs base · derived: price − base caseWhat the price expects ↗
- Price · StockValuer price feed, 2026-11-16 closeno link today
Whisker on the base case runs bear $46.61 to bull $110.80. Values per share.
Price against each value
- Bear case
- $46.61
- Price 117% above
- No growth
- …
- —
- Base case
- $82.50
- Price 22% above
What does Colgate Palmolive do?
Colgate-Palmolive sells oral care, personal care, and home care products, as well as specialty pet nutrition, to consumers and retailers worldwide.
It brought in $21.3B of sales in the 12 months to Sep 2026.
Led by Noel Wallace, Chairman of the Board, President and Chief Executive Officer since 2019. Colgate-Palmolive Form 8-K – Third Quarter 2026 Results Press Release
- Industry
- Materials
- Based in
- New York, New York
- Trades on
- NYSE as CL
Here is where each dollar a customer pays ends up. Out of every $1 of sales in the 12 months to Sep 2026, about 10¢ was left as profit after every cost, interest and tax. The biggest cost is sales, marketing and admin, 39¢ of every dollar.
- Making what it sells39¢
- Sales, marketing and admin39¢
- Everything else it takes to operate6¢
- Interest and other costs1¢
- Tax4¢
- Other items after tax1¢
- Left as profit10¢
Who pays Colgate Palmolive, and for what?
Colgate-Palmolive makes and sells everyday household brands in more than 200 countries. Its products include Colgate toothpaste and toothbrushes, Palmolive and Softsoap soaps, Ajax and Fabuloso cleaners, and Hill's pet food. It earns money by selling these branded products to stores and other sellers. Net sales were about $20.4 billion in 2025.
Most sales go to retailers, wholesalers, distributors, pet stores, veterinarians and online sellers, who then sell to households; Walmart alone made up about 11% of 2025 sales.
Oral Care
44%Toothpaste, manual toothbrushes, mouthwash and products for dentists, under brands such as Colgate, Darlie, elmex, meridol and Tom's of Maine. Colgate had about 41% of the world toothpaste market in 2025.
Pet Nutrition (Hill's)
23%Hill's Science Diet everyday pet food, Hill's Prescription Diet foods for pets with health needs, and Prime100 fresh pet food in Australia. These are sold through pet stores, vets and online sellers.
Personal Care
17%Liquid hand soap, bar soap, shower gel, deodorant, shampoo and skin care, under brands such as Softsoap, Palmolive, Protex, Irish Spring, Speed Stick, EltaMD and Filorga.
Home Care
16%Dishwashing liquids, household cleaners and fabric softeners, under brands such as Ajax, Axion, Palmolive, Fabuloso, Murphy and Suavitel.
Where its work physically happens, beyond headquarters:
- Yangzhou toothbrush plant — Yangzhou, China. Colgate-Palmolive identifies this as its primary toothbrush manufacturing facility and says it produces approximately 1 billion toothbrushes annually.
- Hill’s Tonganoxie smart factory — Tonganoxie, United States. This automated factory expands Hill’s wet pet food production capacity for Colgate-Palmolive’s Pet Nutrition segment.
- Piscataway Global Technology Center — Piscataway, United States. Colgate-Palmolive’s largest global technology center houses clinical research that supports oral care and skin health product development.
- Hill’s Small Paws Innovation Center — Topeka, United States. The $30 million nutrition research center develops foods tailored to small dogs, supporting innovation in Hill’s Pet Nutrition.
- Sanand oral care plant — Sanand, India. This owned oral care plant forms part of Colgate-Palmolive India’s four-plant manufacturing network.
How is the business doing?
Sales grew from $16.5B in 2020 to $20.4B in 2025, about 4% a year.
Running the business leaves about 15¢ of each sales dollar as operating profit, down from 24¢ in 2020.
After paying for its upkeep and new investment, it had $3.8B of cash to spare in the 12 months to Sep 2026.
What does management say it's aiming for?
Colgate says it exists to help make people, their pets and the planet healthier, mainly through science-based products.
“Reimagine a healthier future for all people, their pets and our planet”
Who is responsible for the plan?
- Noel WallaceChairman of the Board, President and Chief Executive Officer
Leads Colgate-Palmolive overall as Chairman, President and CEO. The company makes its money selling Oral Care, Personal Care, Home Care and Pet Nutrition products around the world, and all of these report to the CEO.
- Yvonne HsuPresident, Hill's Pet Nutrition
Leads Hill's Pet Nutrition, the company's pet food business. The FY2025 Form 10-K says Pet Nutrition products made up 23% of the company's worldwide net sales in 2025.
- Stephan HabifChief Technology Officer
Leads Colgate-Palmolive's global Research & Development organization. The R&D group develops the formulas and technology behind the products the company sells in its Oral Care, Personal Care, Home Care and Pet Nutrition categories.
Roles checked November 9, 2026.
What management says it is working on now:
Reaching more households with its brands
Under its 2030 strategy, Colgate wants to make use of how many homes already buy its brands around the world. It says Colgate is the brand found in more homes than any other.
Colgate-Palmolive Form 10-K for fiscal year 2025Science-based new products
Management is focused on launching new and more premium products backed by science. It wants a supply chain that can adapt quickly to support these launches.
Colgate-Palmolive Form 10-K for fiscal year 2025Winning shoppers in stores, online and on social media
Colgate wants to create demand everywhere people shop, including physical stores, online retailers, social media and shopping helped by AI. It is also building its skills in data, analytics and AI.
Colgate-Palmolive Form 10-K for fiscal year 2025Cutting costs to pay for growth
A three-year program approved in July 2025 will reorganise teams, streamline the supply chain and reduce overhead. It is expected to cost $200 to $300 million before tax, mostly by the end of 2028. Ongoing savings programs offset part of higher material costs in 2025.
Colgate-Palmolive Form 10-K for fiscal year 2025Growing cash and returning it to shareholders
Management calls strong free cash flow a key priority. It plans to invest in faster-growing, higher-margin areas of Oral Care, Personal Care and Pet Nutrition, and to return cash through dividends and share buybacks.
Colgate-Palmolive Form 10-K for fiscal year 2025
- Organic sales growth (sales growth excluding currency moves, acquisitions and divestments), Full year 2026 (kept unchanged in July 2026)
- 1% to 4%
- Colgate Announces 2nd Quarter 2026 Results
- Net sales growth, Full year 2026 (kept unchanged in July 2026)
- 2% to 6%
- Colgate Announces 2nd Quarter 2026 Results
- Earnings per share growth (as reported), Full year 2026 (kept unchanged in July 2026)
- Double-digit growth
- Colgate-Palmolive 4th Quarter 2025 results press release (Form 8-K)
What's changing right now?
Growth is holding steady. In Q3 2026 it sold 5% more than a year earlier. The year before, quarters averaged 5%.
Its operating margin is about where it was a year ago, 20¢ per sales dollar.
Since Oct 2026 the share price has risen 8%, from $93.40 to $100.99.
Recently
October 30, 2026
Organic sales growth, quarterly year over year rose to 3.6%
CL Q3 2026 earnings release tables (8-K)October 30, 2026
Capex as a share of net sales, nine months year to date changed to 2.5%
CL Q3 2026 earnings release tables (8-K)October 30, 2026
Company organic sales growth, quarterly changed to 3.6%
Q3 2026 results
Coming up
October 30, 2026, 8:30 a.m. ET
Third-quarter 2026 results
Colgate will report third-quarter results and hold a webcast call. It may update its 2026 sales and earnings guidance.
Colgate-Palmolive Webcasts 2026 Third Quarter Earnings Conference Call October 30, 20262026 and beyond
Possible changes to the US-Mexico-Canada trade agreement
Management says the ongoing rollout and possible renegotiation of the US-Mexico-Canada trade agreement could affect its costs, prices and consumer demand.
Colgate-Palmolive Form 10-K for fiscal year 2025By December 31, 2028
Cost-cutting program reaches completion
The Strategic Growth and Productivity Program is expected to have incurred substantially all of its $200 to $300 million in pre-tax charges by the end of 2028. Its savings are meant to fund growth and protect profits.
Colgate-Palmolive Form 10-K for fiscal year 2025
Our own estimate moved too: the base case went from $80.71 to $82.50 a share between our last two valuations. The biggest reason: Company underlying operating profitability, quarterly moved from an unreported prior value to 20.8%, as reported in Q3 2026 results, Base Business operating profit.
What could go wrong?
No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.
Rising material costs and tariffs
Higher costs for raw materials and packaging lowered the gross profit margin by 4.2 percentage points in 2025, before savings and price increases. New tariffs could raise costs further. Price increases may not fully cover these costs.
From the company's own filingsWould hit how much of each sale it keepsColgate-Palmolive Form 10-K for fiscal year 2025
Weak demand and cheaper store brands
Management expects 2025's slow demand in its product categories to continue into 2026. Shoppers may buy fewer products or switch to cheaper store brands. Large rivals and new online competitors add pressure.
From the company's own filingsWould hit how fast sales growColgate-Palmolive Form 10-K for fiscal year 2025
Currency swings and global instability
About two-thirds of sales come from outside the US. Weaker foreign currencies reduce what those sales are worth in dollars, especially in Argentina, Nigeria and Türkiye. Wars and political turmoil, such as in Ukraine, the Middle East and Venezuela, can also disrupt the business.
From the company's own filingsWould hit how fast sales growColgate-Palmolive Form 10-K for fiscal year 2025
Powerful retail customers
Colgate increasingly depends on a few large retailers, and Walmart alone is about 11% of sales. These retailers can push for bigger discounts, fees and advertising spend. They can also stop carrying some products.
From the company's own filingsWould hit how much of each sale it keepsColgate-Palmolive Form 10-K for fiscal year 2025
Acquisitions that fall short
In late 2025 Colgate wrote down the value of its skin health business, mainly Filorga, by $794 million after tax. Growth was slower than expected, especially in China. Future deals could disappoint in the same way.
From the company's own filingsWould hit how fast sales growColgate-Palmolive Form 10-K for fiscal year 2025
Rules on product ingredients
Regulators are looking more closely at ingredients such as fluoride, titanium dioxide, synthetic colors and PFAS, a group of long-lasting chemicals. New limits could force Colgate to change its products or hurt sales and its reputation.
From the company's own filingsWould hit how fast sales growColgate-Palmolive Form 10-K for fiscal year 2025
Management continues to describe consumer uncertainty and macroeconomic volatility.
From our researchWould hit how fast sales growQ3 2026 prepared remarks
Negative working capital helps finance operations.
From our researchWould hit how much it has to reinvestQ3 2026 Form 10-Q
Is it a good business?
From 2016 to 2025 it earned between 25% and 57% on the capital invested in it, a median of 38%. Its cost of capital in the latest valuation is 7.0%; returns were above it in every one of the 10 years.
From 2019 to 2025 it earned between 356% and 3,946% on its shareholders' equity, a median of 445%.
Over 10 years its operating margin ranged from 16¢ to 25¢ per sales dollar, a median of 22¢. Gross margin ran from 57¢ to 61¢.
Cost of capital 7.0%
It bought back shares: the count fell 1.3% in a year, so each remaining share owns a slightly bigger slice.
It owes $6.2B more than it holds in cash, about 2.0 years of operating profit.
What might it be worth?
The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .
Today a share costs $100.99. Our put its value between $46.61 and $110.80, with $82.50 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .
Bear case, $46.61
The recent sales recovery fades, while higher costs and continued spending leave Colgate keeping less profit from each sale.
Base case, $82.50
Colgate builds on its recent sales recovery, with toothpaste and pet food supporting steady growth and gradually better profits.
Bull case, $110.80
The recent sales and profit recovery strengthens as more shoppers choose Colgate's premium toothpaste and pet food, while its factories become more productive.
Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.
Why the gap?
The price expects more than we do.Price above value: 22%
For Colgate Palmolive to be worth today's $100.99, sales would need to grow about 7.9% a year. We assume 3.7%. Over the last 5 years, sales grew 4.2% a year.
Or, if sales grow 3.7% as we assume, the price works with a profit margin of 26.5% (we assume 22.0%).
Keep in mind: this is one way to read the price. Investors might be expecting other things, like higher profits or lower risk.
Do you think sales can grow 7.9% a year?
Try your own numbersWe're moderately sure of this range: it scores 61 out of 100 on our checks. The weakest point is terminal-value dependency.
Test the assumptions
Our base value of $82.50 rests on three assumptions. Change any of them to see how the value per share responds.
- Revenue growth, 5-year average3.7%
- Operating margin22.0%
- Long-term growth rate2.5%
This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.
Base estimate
$82.50 -18.3%

